A phase I/II study of systemic ADH-1 in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma
Publication
, Conference
Beasley, G; McMahon, N; Sanders, G; Zipfel, P; Augustine, C; Petros, W; Padussis, J; Ross, MI; Selim, A; Peters, W; Tyler, DS
Published in: Journal of Clinical Oncology
May 20, 2008
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2008
Volume
26
Issue
15_suppl
Start / End Page
9013 / 9013
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Beasley, G., McMahon, N., Sanders, G., Zipfel, P., Augustine, C., Petros, W., … Tyler, D. S. (2008). A phase I/II study of systemic ADH-1 in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma. In Journal of Clinical Oncology (Vol. 26, pp. 9013–9013). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2008.26.15_suppl.9013
Beasley, G., N. McMahon, G. Sanders, P. Zipfel, C. Augustine, W. Petros, J. Padussis, et al. “A phase I/II study of systemic ADH-1 in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma.” In Journal of Clinical Oncology, 26:9013–9013. American Society of Clinical Oncology (ASCO), 2008. https://doi.org/10.1200/jco.2008.26.15_suppl.9013.
Beasley G, McMahon N, Sanders G, Zipfel P, Augustine C, Petros W, et al. A phase I/II study of systemic ADH-1 in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 9013–9013.
Beasley, G., et al. “A phase I/II study of systemic ADH-1 in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma.” Journal of Clinical Oncology, vol. 26, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2008, pp. 9013–9013. Crossref, doi:10.1200/jco.2008.26.15_suppl.9013.
Beasley G, McMahon N, Sanders G, Zipfel P, Augustine C, Petros W, Padussis J, Ross MI, Selim A, Peters W, Tyler DS. A phase I/II study of systemic ADH-1 in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 9013–9013.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2008
Volume
26
Issue
15_suppl
Start / End Page
9013 / 9013
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences